Pyrethrum Root

Pyrethrum root (Anacyclus pyrethrum) contains structurally unprecedented N-alkylamides—pellitorin, anacyclin, and the spiro-fused anacyphrethines A and B—that dual-inhibit COX-2 (IC₅₀ 5.11–10.79 μM) and 5-LOX (IC₅₀ 7.28–12.18 μM) while acting as multiple ion channel inhibitors to produce potent analgesic and anti-inflammatory effects (PMID: 40698126). In vivo, methanol and aqueous root extracts achieved 94.10% analgesic efficacy at 300 mg/kg in Swiss albino mice with anti-inflammatory activity comparable to diclofenac (10 mg/kg), alongside significant DPPH and ABTS radical-scavenging capacity (PMID: 28928658).

Origin & History

Pyrethrum root is derived from the plant species Chrysanthemum cinerariifolium, native to East Africa, particularly Kenya and Tanzania. Traditionally recognized for its insecticidal properties, it is also explored in functional nutrition for its potential immune-modulating and anti-inflammatory compounds.

Historical & Cultural Context

Pyrethrum root has been traditionally used in East African herbal medicine to treat fevers, infections, respiratory conditions, and pain. It was also incorporated into cleansing rituals to promote purification and protection.

Health Benefits

- **Supports immune resilience**: by modulating inflammatory pathways.
- **Alleviates musculoskeletal pain**: through its anti-inflammatory compounds.
- **Enhances cognitive clarity**: by supporting healthy circulation and reducing oxidative stress.
- **Promotes respiratory wellness**: by reducing inflammation in air passages.
- **Contributes to skin**: vitality through antioxidant protection and antimicrobial effects.
- **Aids in detoxification**: processes by supporting liver enzyme activity.

How It Works

The primary bioactive N-alkylamides of pyrethrum root—pellitorin, anacyclin, and the structurally novel anacyphrethines A and B—selectively inhibit cyclooxygenase-2 (COX-2) at IC₅₀ values of 5.11–10.79 μM and 5-lipoxygenase (5-LOX) at IC₅₀ 7.28–12.18 μM, thereby suppressing both prostaglandin E₂ and leukotriene biosynthesis while sparing the constitutive COX-1 enzyme (PMID: 40698126). Anacyphrethines A and B additionally function as multiple ion channel inhibitors—modulating TRPV1, sodium, and potassium channels—which accounts for their pronounced analgesic and local anesthetic properties and their traditional use against toothache and neuropathic pain (PMID: 40698126; PMID: 38692343). In respiratory models, ethanol root extracts downregulate the TLR4/NF-κB inflammatory cascade and the Wnt/β-catenin signaling pathway, reducing pro-inflammatory cytokine release (TNF-α, IL-6, IL-1β) and ameliorating airway hyperresponsiveness (PMID: 37910337). Emerging evidence from integrated network pharmacology and gut microbiome analysis suggests pyrethrum root also modulates the gut-brain axis, influencing dopaminergic and cholinergic neurotransmission relevant to cognitive decline in neurodegenerative conditions (PMID: 40253741).

Scientific Research

Manouze et al. (2017) demonstrated in Swiss albino mice that methanol and aqueous Anacyclus pyrethrum root extracts produced 94.10% analgesic efficacy at 300 mg/kg and anti-inflammatory activity comparable to diclofenac (10 mg/kg) in carrageenan-induced paw edema, with significant DPPH and ABTS radical-scavenging capacity (Frontiers in Pharmacology, PMID: 28928658). Chen et al. (2025) isolated anacyphrethines A and B—compounds featuring an unprecedented spiro-fused chemical architecture—and demonstrated they function as multiple ion channel inhibitors with potent analgesic activity and dual COX-2/5-LOX inhibition at low-micromolar concentrations (Acta Pharmaceutica Sinica B, PMID: 40698126). Tuersong et al. (2025) employed integrated network pharmacology, metabolomics, and microbiome analysis to reveal that Anacyclus pyrethrum exerts therapeutic effects in Parkinson's disease with mild cognitive impairment (PD-MCI) mice, implicating gut-brain axis modulation (Phytomedicine, PMID: 40253741). Zheng et al. (2024) showed that ethanol extract of A. pyrethrum root ameliorated cough-variant asthma through suppression of the TLR4/NF-κB and Wnt/β-catenin signaling pathways, reducing airway inflammation in an animal model (Molecular Biotechnology, PMID: 37910337).

Clinical Summary

Current evidence for pyrethrum root is limited to in vitro, animal studies, and traditional use documentation, with no published human clinical trials available. Animal studies show 94.10% analgesic efficacy at 300 mg/kg dosing, superior to diclofenac's 43% pain reduction in acetic acid-induced abdominal contractions. Anti-inflammatory effects reach up to 98% inhibition in animal models, with wound healing acceleration up to 100%. The moderate acute toxicity profile shows an LD50 of 45.847 mg/ml in extract form, indicating the need for careful dosing protocols in any future human applications.

Nutritional Profile

- Pyrethrins: Bioactive compounds with insecticidal and potential anti-inflammatory properties.
- Flavonoids: Including quercetin and kaempferol, provide antioxidant and anti-inflammatory benefits.
- Terpenoids: Contribute to its aromatic and bioactive profile.
- Minerals: Calcium, magnesium, and potassium for musculoskeletal and nerve support.
- Saponins and Alkaloids: Contribute to various traditional medicinal uses.

Preparation & Dosage

- Consume 500–1000 mg of extract daily under professional supervision.
- Brew 1–2 grams of dried root in hot water for 10–15 minutes, up to twice daily.

Synergy & Pairings

Role: Polyphenol/antioxidant base
Intention: Cognition & Focus | Detox & Liver
Primary Pairings: - Turmeric (Curcuma longa)
- Ginger (Zingiber officinale)
- Ashwagandha (Withania somnifera)
- Echinacea purpurea

Safety & Interactions

Acute toxicity evaluation by Jawhari et al. (2021) in Swiss mice found that aqueous and methanol extracts of both Anacyclus pyrethrum var. pyrethrum and var. depressus exhibited no mortality at tested doses, suggesting a relatively favorable acute safety profile, though subchronic and chronic toxicity data remain limited (PMID: 33776312). Due to its potent COX-2 and 5-LOX inhibition, pyrethrum root may theoretically potentiate the effects of NSAIDs, anticoagulants (e.g., warfarin), and antiplatelet agents, increasing bleeding risk; concurrent use warrants clinical caution. No formal CYP450 interaction studies have been published for A. pyrethrum, but the alkaloid-rich profile (including neopellitorine and related compounds, PMID: 38692343; PMID: 39216630) suggests potential for hepatic enzyme interactions, particularly CYP3A4 and CYP2D6, warranting caution with narrow-therapeutic-index drugs. Pregnant and breastfeeding women should avoid pyrethrum root due to insufficient human safety data, and individuals with known Asteraceae/Compositae allergies may experience cross-reactive hypersensitivity.